Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.65
-0.05-2.94%
At close: -
$1.60
-0.05-3.03%
After Hours: 5:42 PM EDT
Comments
Loading...
Metagenomi Analyst Ratings and Price Targets | NASDAQ:MGX | Benzinga
Metagenomi Inc has a consensus price target of $13.5 based on the ratings of 7 analysts. The high is $23 issued by Jefferies on March 5, 2024. The low is $6 issued by JP Morgan on May 2, 2024. The 3 most-recent analyst ratings were released by Chardan Capital, Wells Fargo, and HC Wainwright & Co. on May 15, 2025, May 14, 2025, and April 3, 2025, respectively. With an average price target of $11.67 between Chardan Capital, Wells Fargo, and HC Wainwright & Co., there's an implied 629.17% upside for Metagenomi Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Chardan Capital
Wells Fargo
HC Wainwright & Co.
BMO Capital
JP Morgan
1calculated from analyst ratings
Analyst Ratings for Metagenomi
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2025 | Buy Now | 650% | Chardan Capital | Geulah Livshits46% | $13 → $12 | Maintains | Buy | Get Alert |
| 05/14/2025 | Buy Now | 900% | Wells Fargo | Yanan Zhu40% | $20 → $16 | Maintains | Overweight | Get Alert |
| 04/03/2025 | Buy Now | 337.5% | HC Wainwright & Co. | Mitchell Kapoor44% | $14 → $7 | Maintains | Buy | Get Alert |
| 03/18/2025 | Buy Now | 1150% | Wells Fargo | Yanan Zhu40% | $25 → $20 | Maintains | Overweight | Get Alert |
| 12/10/2024 | Buy Now | 775% | HC Wainwright & Co. | Mitchell Kapoor44% | $7 → $14 | Maintains | Buy | Get Alert |
| 11/21/2024 | Buy Now | 337.5% | HC Wainwright & Co. | Mitchell Kapoor44% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 11/20/2024 | Buy Now | 837.5% | Chardan Capital | Geulah Livshits46% | $15 → $15 | Maintains | Buy | Get Alert |
| 10/15/2024 | Buy Now | 337.5% | HC Wainwright & Co. | Mitchell Kapoor44% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2024 | Buy Now | 337.5% | HC Wainwright & Co. | Mitchell Kapoor44% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | Buy Now | 837.5% | Chardan Capital | Geulah Livshits46% | $15 → $15 | Maintains | Buy | Get Alert |
| 08/21/2024 | Buy Now | 337.5% | HC Wainwright & Co. | Mitchell Kapoor44% | $10 → $7 | Maintains | Buy | Get Alert |
| 08/19/2024 | Buy Now | 837.5% | Chardan Capital | Geulah Livshits46% | $17 → $15 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | 962.5% | BMO Capital | Kostas Biliouris33% | $22 → $17 | Maintains | Outperform | Get Alert |
| 07/15/2024 | Buy Now | 525% | HC Wainwright & Co. | Mitchell Kapoor44% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | 525% | HC Wainwright & Co. | Mitchell Kapoor44% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | 525% | HC Wainwright & Co. | Mitchell Kapoor44% | → $10 | Initiates | → Buy | Get Alert |
| 05/02/2024 | Buy Now | 275% | JP Morgan | Brian Cheng38% | $16 → $6 | Downgrade | Overweight → Neutral | Get Alert |
| 03/28/2024 | Buy Now | 1212.5% | Chardan Capital | Geulah Livshits46% | $21 → $21 | Maintains | Buy | Get Alert |
| 03/05/2024 | Buy Now | 1275% | BMO Capital | Kostas Biliouris33% | → $22 | Initiates | → Outperform | Get Alert |
| 03/05/2024 | Buy Now | — | TD Cowen | Joseph Thome26% | — | Initiates | → Outperform | Get Alert |
| 03/05/2024 | Buy Now | 1462.5% | Wells Fargo | Yanan Zhu40% | → $25 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | 900% | JP Morgan | Brian Cheng38% | → $16 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | 1337.5% | Jefferies | Maury Raycroft32% | → $23 | Initiates | → Buy | Get Alert |
| 03/05/2024 | Buy Now | 1212.5% | Chardan Capital | Geulah Livshits46% | → $21 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Metagenomi (MGX) stock?
The latest price target for Metagenomi (NASDAQ:MGX) was reported by Chardan Capital on May 15, 2025. The analyst firm set a price target for $12.00 expecting MGX to rise to within 12 months (a possible 650.00% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Metagenomi (MGX)?
The latest analyst rating for Metagenomi (NASDAQ:MGX) was provided by Chardan Capital, and Metagenomi maintained their buy rating.
When was the last upgrade for Metagenomi (MGX)?
There is no last upgrade for Metagenomi
When was the last downgrade for Metagenomi (MGX)?
The last downgrade for Metagenomi Inc happened on May 2, 2024 when JP Morgan changed their price target from $16 to $6 for Metagenomi Inc.
When is the next analyst rating going to be posted or updated for Metagenomi (MGX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Metagenomi, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Metagenomi was filed on May 15, 2025 so you should expect the next rating to be made available sometime around May 15, 2026.
Is the Analyst Rating Metagenomi (MGX) correct?
While ratings are subjective and will change, the latest Metagenomi (MGX) rating was a maintained with a price target of $13.00 to $12.00. The current price Metagenomi (MGX) is trading at is $1.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
